Cryoport Inc
CYRX5.469USD
-0.110-1.98%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
272.97MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Cryoport Inc Unternehmen
Cryoport, Inc. provides supply chain solutions for the Life Sciences with a focus on cell and gene therapies. The Company enables manufacturers, contract manufacturers, contract research organizations, developers, and researchers to carry out their respective business with products and services. It provides a range of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories.
Unternehmensinformationen
Unternehmens-codeCYRX
Name des UnternehmensCryoport Inc
IPO-datumJul 24, 2015
Gegründet am1990
CEOMr. Jerrell Wilson (Jerry) Shelton
Anzahl der mitarbeiter1090
WertpapierartOrdinary Share
GeschäftsjahresendeJul 24
Addresse112 Westwood Place, Suite 350
StadtBRENTWOOD
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl37027
Telefon19492321900
Websitehttps://www.cryoport.com/
Unternehmens-codeCYRX
IPO-datumJul 24, 2015
Gegründet am1990
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
706.97K
+3.89%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
27.38K
+88.35%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
26.43K
+94.55%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
11.96K
-17.29%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Richard J. Berman
Mr. Richard J. Berman
Lead Independent Director
Lead Independent Director
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
706.97K
+3.89%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
27.38K
+88.35%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
26.43K
+94.55%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
11.96K
-17.29%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
BioLogistics solutions
138.63M
60.70%
Life Science products
74.72M
32.72%
BioStorage/Bioservices
15.03M
6.58%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
126.37M
55.33%
Europe & Middle East & Africa (EMEA)
59.60M
26.09%
Asia Pacific
42.42M
18.57%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
BioLogistics solutions
138.63M
60.70%
Life Science products
74.72M
32.72%
BioStorage/Bioservices
15.03M
6.58%
Aktionäre
Update-Zeit: Sun, Feb 23
Update-Zeit: Sun, Feb 23
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Cadian Capital Management LP
9.83%
Morgan Stanley & Co. LLC
9.20%
Brown Capital Management, LLC
8.89%
Millennium Management LLC
8.26%
BlackRock Institutional Trust Company, N.A.
6.03%
Other
57.80%
Aktionärsstatistik
Aktionäre
Anteil
Cadian Capital Management LP
9.83%
Morgan Stanley & Co. LLC
9.20%
Brown Capital Management, LLC
8.89%
Millennium Management LLC
8.26%
BlackRock Institutional Trust Company, N.A.
6.03%
Other
57.80%
Art
Aktionäre
Anteil
Investment Advisor
34.73%
Investment Advisor/Hedge Fund
27.63%
Hedge Fund
23.30%
Research Firm
10.71%
Individual Investor
2.75%
Pension Fund
2.55%
Sovereign Wealth Fund
0.70%
Private Equity
0.61%
Bank and Trust
0.15%
Institutionelle Beteiligung
Update-Zeit: Mon, Mar 3
Update-Zeit: Mon, Mar 3
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
394
51.74M
103.20%
-14.27M
2024Q4
407
51.87M
104.93%
-14.28M
2024Q3
422
52.00M
105.24%
-13.61M
2024Q2
423
53.55M
108.72%
-9.95M
2024Q1
437
55.31M
112.51%
-7.56M
2023Q4
468
54.03M
110.37%
-6.18M
2023Q3
482
49.41M
101.04%
-7.52M
2023Q2
492
49.81M
109.19%
-5.40M
2023Q1
500
48.02M
99.15%
-8.43M
2022Q4
513
48.06M
98.07%
-6.28M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Cadian Capital Management LP
4.93M
9.87%
+609.02K
+14.10%
Dec 31, 2024
Morgan Stanley & Co. LLC
4.61M
9.24%
+1.32K
+0.03%
Dec 31, 2024
Brown Capital Management, LLC
4.46M
8.93%
-692.65K
-13.45%
Dec 31, 2024
Millennium Management LLC
4.14M
8.29%
+409.35K
+10.97%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
3.02M
6.06%
-18.57K
-0.61%
Dec 31, 2024
The Vanguard Group, Inc.
2.73M
5.47%
-97.22K
-3.44%
Dec 31, 2024
Fred Alger Management, LLC
2.57M
5.14%
-131.83K
-4.88%
Dec 31, 2024
Natixis Investment Managers SA
1.71M
3.43%
--
--
Dec 31, 2024
DWS Investments UK Limited
1.40M
2.8%
+12.86K
+0.93%
Dec 31, 2024
New York State Common Retirement Fund
1.15M
2.3%
-37.55K
-3.17%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
Invesco NASDAQ Future Gen 200 ETF
0.4%
Inspire Small/Mid Cap ESG ETF
0.16%
JPMorgan Fundamental Data Science Small Core ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Mehr Anzeigen
Invesco NASDAQ Future Gen 200 ETF
Anteil0.4%
Inspire Small/Mid Cap ESG ETF
Anteil0.16%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.03%
Avantis US Small Cap Equity ETF
Anteil0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
Anteil0.01%
Schwab U.S. Small-Cap ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten